Consumer Health in Uzbekistan

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,650	80 Pages	Euromonitor International	October, 2022	EP17462573

Attention: There is an updated edition available for this report.

Best Price Guarantee
Price	from $2,650
Length	80 Pages
Publisher	Euromonitor International
Published Date	October, 2022
SKU	EP17462573

Consumer Health in Uzbekistan

Consumer health witnessed an improved performance in both volume and current value terms in 2022, as the country continued to recover from the effects of the COVID-19 pandemic. A sharp increase in unit prices, due to inflationary pressures, boosted retail current value growth. Uzbekistan is reliant on imported products and raw materials, rendering it vulnerable to global changes in supply and demand. In 2022, the lingering effects of the COVID-19 pandemic continued to cause disruption to supply...

Euromonitor International's Consumer Health in Uzbekistan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Consumer Health in Uzbekistan
Euromonitor International
October 2022
List Of Contents And Tables
CONSUMER HEALTH IN UZBEKISTAN
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS: Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022; Table 2 Life Expectancy at Birth 2017-2022
MARKET DATA: Table 3 Sales of Consumer Health by Category: Value 2017-2022; Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022; Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022; Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022; Table 7 Distribution of Consumer Health by Format: % Value 2017-2022; Table 8 Distribution of Consumer Health by Format and Category: % Value 2022; Table 9 Forecast Sales of Consumer Health by Category: Value 2022-2027; Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES: Summary 1 Research Sources
ANALGESICS IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Slower growth in 2022, following boom caused by COVID-19
Low-cost brands continue to be in high demand
Domestic brands retain their grip, amid ongoing barriers to foreign investment
PROSPECTS AND OPPORTUNITIES
Much potential for growth
Children’s analgesics to be supported by high birth rates
Local producers to strengthen their position, as Russian brands face logistical issues
CATEGORY DATA: Table 11 Sales of Analgesics by Category: Value 2017-2022; Table 12 Sales of Analgesics by Category: % Value Growth 2017-2022; Table 13 NBO Company Shares of Analgesics: % Value 2018-2022; Table 14 LBN Brand Shares of Analgesics: % Value 2019-2022; Table 15 Forecast Sales of Analgesics by Category: Value 2022-2027; Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to pre-pandemic lifestyles boosts sales of cough and cold remedies.
Allergy and hay fever remedies make a comeback as pandemic restrictions lift
Ajanta Pharma maintains its lead , as domestic companies struggle to compete with global and regional players
PROSPECTS AND OPPORTUNITIES
Scope for growth in unsaturated category
Demand for paediatric medicines will continue to bolster sales
Economy segment to see increased competition in the form of local brands
CATEGORY DATA: Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022; Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022; Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022; Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022; Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027; Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
DIGESTIVE REMEDIES IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Accelerated growth in 2022, following the end of COVID-19 restrictions
Consumption of rich, fatty foods, engenders a range of digestive issues
Global companies grow their stronghold
PROSPECTS AND OPPORTUNITIES
More modest growth expected, amid enduring consumer price sensitivity
Healthier diets and lifestyles in higher-income urban consumers will suppress sales
Domestic players will maintain only small shares, despite government support
CATEGORY DATA: Table 23 Sales of Digestive Remedies by Category: Value 2017-2022; Table 24 Sales of Digestive Remedies by Category: % Value Growth 2017-2022; Table 25 NBO Company Shares of Digestive Remedies: % Value 2018-2022; Table 26 LBN Brand Shares of Digestive Remedies: % Value 2019-2022; Table 27 Forecast Sales of Digestive Remedies by Category: Value 2022-2027; Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
DERMATOLOGICALS IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Certain treatments see a rebound in 2022, but sales remain underdeveloped
Paediatric dermatologicals see varying levels of demand
Global players lead sales, but domestic players still play a key role amongst price conscious consumers
PROSPECTS AND OPPORTUNITIES
Future development of dermatologicals will depend on the Uzbekistan economy
Products deemed as essential will support ongoing growth
Global brands to remain dominant
CATEGORY DATA: Table 29 Sales of Dermatologicals by Category: Value 2017-2022; Table 30 Sales of Dermatologicals by Category: % Value Growth 2017-2022; Table 31 NBO Company Shares of Dermatologicals: % Value 2018-2022; Table 32 LBN Brand Shares of Dermatologicals: % Value 2019-2022; Table 33 Forecast Sales of Dermatologicals by Category: Value 2022-2027; Table 34 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
WOUND CARE IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Saturation leaves little room for new product development
Price remains a key factor in consumers’ purchasing decisions
Domestic player Sarbontex benefits from continuing demand for low-cost products
PROSPECTS AND OPPORTUNITIES
Very little change expected over the forecast period
Lack of sporting culture dampens demand for wound care
Increasing presence of pharmacies to ensure continued modest growth in wound care
CATEGORY DATA: Table 35 Sales of Wound Care by Category: Value 2017-2022; Table 36 Sales of Wound Care by Category: % Value Growth 2017-2022; Table 37 NBO Company Shares of Wound Care: % Value 2018-2022; Table 38 LBN Brand Shares of Wound Care: % Value 2019-2022; Table 39 Forecast Sales of Wound Care by Category: Value 2022-2027; Table 40 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
VITAMINS IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Return to normal purchasing behaviour, following a spike in sales in 2020
Multivitamins remains the largest category in terms of sales, while immune-booting properties of vitamins C and D are valued by consumers
Multinationals hold sway over smaller domestic players in increasingly fragmented landscape
PROSPECTS AND OPPORTUNITIES
Slower growth expected, following a spike in popularity during COVD-19
Paediatric vitamins will remain popular, as parents prioritise their children’s health over their own
Fragmentation to remain over the forecast period
CATEGORY DATA: Table 41 Sales of Vitamins by Category: Value 2017-2022; Table 42 Sales of Vitamins by Category: % Value Growth 2017-2022; Table 43 Sales of Multivitamins by Positioning: % Value 2017-2022; Table 44 NBO Company Shares of Vitamins: % Value 2018-2022; Table 45 LBN Brand Shares of Vitamins: % Value 2019-2022; Table 46 Forecast Sales of Vitamins by Category: Value 2022-2027; Table 47 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
DIETARY SUPPLEMENTS IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Upper-income consumers reach out to health-boosting supplements, as the market recovers from the pandemic
Paediatric products benefit from healthy demand, as consumers prioritise their children’s health
Sanofi’s Magne B6 brand continues to hold the top spot, having benefited from the trend towards busier lifestyles
PROSPECTS AND OPPORTUNITIES
Dietary supplements to see slower growth, due to their status as non-essential products
Combination products with clear health benefits will be the most popular
Domestic players on the rise, thanks to increased government support
CATEGORY DATA: Table 48 Sales of Dietary Supplements by Category: Value 2017-2022; Table 49 Sales of Dietary Supplements by Category: % Value Growth 2017-2022; Table 50 Sales of Dietary Supplements by Positioning: % Value 2017-2022; Table 51 NBO Company Shares of Dietary Supplements: % Value 2018-2022; Table 52 LBN Brand Shares of Dietary Supplements: % Value 2019-2022; Table 53 Forecast Sales of Dietary Supplements by Category: Value 2022-2027; Table 54 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
WEIGHT MANAGEMENT AND WELLBEING IN UZBEKISTAN
2022 DEVELOPMENTS
Weight management and wellbeing remains underdeveloped
Local player Zamona Rano enjoys some success, thanks to marketing investment
Weight loss supplements dominate sales
PROSPECTS AND OPPORTUNITIES
Sales will remain underdeveloped due to a lack of concern over obesity and high degree of scepticism amongst consumers
Gradually emerging interest amongst Uzbek women in controlling their weight
Weight control projects could boost sales
SPORTS NUTRITION IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Niche category of sports nutrition continues its recovery in 2022, as fitness centres and gymnasiums reopen for business
Greater knowledge of sports nutrition helps to boost sales, although usage remains limited mainly to urban consumers
Multinationals Weider and Optimum Nutrition maintain leads in the competitive landscape of sports nutrition
PROSPECTS AND OPPORTUNITIES
Health and wellness trends on the rise in urban areas
Sales will remain focused on protein powder, with little diversification
E-commerce set to be the most promising channel for sports nutrition
CATEGORY DATA: Table 55 Sales of Sports Nutrition by Category: Value 2017-2022; Table 56 Sales of Sports Nutrition by Category: % Value Growth 2017-2022; Table 57 NBO Company Shares of Sports Nutrition: % Value 2018-2022; Table 58 LBN Brand Shares of Sports Nutrition: % Value 2019-2022; Table 59 Forecast Sales of Sports Nutrition by Category: Value 2022-2027; Table 60 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
HERBAL/TRADITIONAL PRODUCTS IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Herbal/traditional products sees an upturn in demand, as lifestyles normalise following the pandemic
Herbal/traditional sleep aids and cough, cold and allergy (hay fever) remedies remain the largest in terms of sales, albeit with differing fortunes in 2022
Affordability and availability remain the key drivers for sales, with Lek Pharmaceuticals maintaining its lead in a fragmented landscape
PROSPECTS AND OPPORTUNITIES
Number of local players likely to grow, but lack of regulation will continue to facilitate production and sale of counterfeit products
No significant developments expected
Low prices may help to boost volume sales over the forecast period
CATEGORY DATA: Table 61 Sales of Herbal/Traditional Products: Value 2017-2022; Table 62 Sales of Herbal/Traditional Products: % Value Growth 2017-2022; Table 63 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022; Table 64 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022; Table 65 Forecast Sales of Herbal/Traditional Products: Value 2022-2027; Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2022-2027
PAEDIATRIC CONSUMER HEALTH IN UZBEKISTAN
KEY DATA FINDINGS
2022 DEVELOPMENTS
Willingness amongst parents to purchase more expensive products, to safeguard their children’s health
Favourable demographics help to sustain growth
Parents remain loyal to trusted brands
PROSPECTS AND OPPORTUNITIES
Paediatric analgesics to lead growth over the forecast period
Predicted decline in birth rate to be tempered by improvements in paediatric healthcare provision
Locally-produced herbal options to remain popular amongst low-income consumers
CATEGORY DATA: Table 67 Sales of Paediatric Consumer Health by Category: Value 2017-2022; Table 68 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022; Table 69 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022; Table 70 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027; Table 71 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027